Mathias Linnerbauer

Dr. Mathias Linnerbauer

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2020 in Neuron
Verified
Journal Article
Closed access
MLMathias Linnerbauer
Mathias Linnerbauer
MWMichael Wheeler
Michael Wheeler
FQFrancisco J. Quintana
Francisco J. Quintana

6 January 2021 in Nature
Verified
Journal Article
Closed access
PDF file
LSLiliana M. Sanmarco
Liliana M. Sanmarco
MWMichael A. Wheeler
Michael A. Wheeler
CGCristina Gutiérrez-Vázquez
Cristina Gutiérrez-Vázquez
CPCarolina Manganeli Polonio
Carolina Manganeli Polonio
MLMathias Linnerbauer
Mathias Linnerbauer
FQFrancisco J. Quintana
Francisco J. Quintana

23 April 2021 in Science
Verified
Journal Article
Closed access
PDF file
ICIain C. Clark
Iain C. Clark
CGCristina Gutiérrez-Vázquez
Cristina Gutiérrez-Vázquez
MWMichael Wheeler
Michael Wheeler
ZLZhaorong Li
Zhaorong Li
VRVeit Rothhammer
Veit Rothhammer
FQFrancisco J. Quintana
Francisco J. Quintana
Single-cell analysis of CNS interactions: Despite their importance in the physiology and pathology of the central nervous system (CNS), few methods are available for the unbiased, systematic investigation of cell-to-cell interactions at single-cell resolution. Clark et al. developed RABID-seq, a method that combines barcoded viral tracing with single-cell RNA sequencing (see the Perspective by Silvin and Ginhoux). RABID-seq identified the axon guidance molecules Sema4D-PlexinB2 and EphrinB3-EphB3 as mediators of microglia-astrocyte interactions that promote CNS pathology in experimental autoimmune encephalomyelitis and, potentially, multiple sclerosis. These studies also identified candidate therapeutic molecules for the modulation of microglia-astrocyte interactions in multiple sclerosis. Science , this issue p. eabf1230 ; see also p. 342

9 August 2023 in Nature
Verified
Journal Article
Closed access
PDF file
LSLiliana M. Sanmarco
Liliana M. Sanmarco
JRJoseph M. Rone
Joseph M. Rone
Carolina Manganeli PolonioCarolina Manganeli Polonio
Carolina Manganeli Polonio
GLGonzalo Fernandez Lahore
Gonzalo Fernandez Lahore
FGFederico Giovannoni
Federico Giovannoni
FQFrancisco J. Quintana
Francisco J. Quintana

20 October 2022 in Nature
Verified
Journal Article
Closed access
PDF file
LSLiliana M. Sanmarco
Liliana M. Sanmarco
CCChun-Cheih Chao
Chun-Cheih Chao
YWYu-Chao Wang
Yu-Chao Wang
JKJessica E. Kenison
Jessica E. Kenison
ZLZhaorong Li
Zhaorong Li
FQFrancisco J. Quintana
Francisco J. Quintana

10 March 2023 in Science
Verified
Journal Article
Closed access
MWMichael Wheeler
Michael Wheeler
ICIain C. Clark
Iain C. Clark
HLHong-Gyun Lee
Hong-Gyun Lee
ZLZhaorong Li
Zhaorong Li
MLMathias Linnerbauer
Mathias Linnerbauer
FQFrancisco J. Quintana
Francisco J. Quintana
Cell–cell interactions in the central nervous system play important roles in neurologic diseases. However, little is known about the specific molecular pathways involved, and methods for their systematic identification are limited. Here, we developed a forward genetic screening platform that combines CRISPR-Cas9 perturbations, cell coculture in picoliter droplets, and microfluidic-based fluorescence-activated droplet sorting to identify mechanisms of cell–cell communication. We used SPEAC-seq (systematic perturbation of encapsulated associated cells followed by sequencing), in combination with in vivo genetic perturbations, to identify microglia-produced amphiregulin as a suppressor of disease-promoting astrocyte responses in multiple sclerosis preclinical models and clinical samples. Thus, SPEAC-seq enables the high-throughput systematic identification of cell–cell communication mechanisms.